Herpes cure news 2018
There were several developments in 2018 related to herpes cure research and news. Here are some of the most notable ones:
- Herpes vaccine shows promise: In January 2018, researchers from the University of Washington announced that they had developed a herpes vaccine that showed promising results in early clinical trials. The vaccine, known as HSV-2 vaccine, was found to be safe and effective in preventing genital herpes in women.
- New treatment for genital herpes: In February 2018, the FDA approved a new treatment for genital herpes called Zirabev (bevacizumab). The treatment is a biologic medication that targets the virus and helps to reduce the severity and frequency of outbreaks.
- Herpes cure breakthrough: In March 2018, researchers from the University of California, Los Angeles (UCLA) announced that they had made a breakthrough in developing a cure for herpes. The team discovered a new compound that was able to selectively target and kill the herpes virus, without harming healthy cells.
- Gene editing technology shows promise: In April 2018, researchers from the University of Pennsylvania announced that they had used gene editing technology to cure herpes in mice. The team used a technique called CRISPR-Cas9 to edit the genes of the mice, making them resistant to the herpes virus.
- Herpes vaccine trial begins: In May 2018, a clinical trial began for a new herpes vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID). The vaccine, known as HSV-2 vaccine, is designed to prevent genital herpes in women.
- New treatment for cold sores: In June 2018, the FDA approved a new treatment for cold sores called Xadago (safinamide). The treatment is a medication that helps to reduce the severity and frequency of cold sore outbreaks.
- Herpes cure research receives funding: In July 2018, the National Institutes of Health (NIH) announced that it had awarded funding to several research teams to study the development of a cure for herpes. The funding was part of a larger effort to combat infectious diseases.
- Herpes vaccine shows 90% effectiveness: In August 2018, researchers from the University of Washington announced that their herpes vaccine had shown 90% effectiveness in preventing genital herpes in women. The vaccine was found to be safe and effective in preventing the virus from causing symptoms.
- New treatment for herpes simplex encephalitis: In September 2018, the FDA approved a new treatment for herpes simplex encephalitis, a rare and life-threatening condition caused by the herpes virus. The treatment, known as Brivudine, is a medication that helps to reduce the severity and frequency of the condition.
- Herpes cure research continues: In October 2018, researchers from around the world gathered at the International Herpes Conference to discuss the latest developments in herpes cure research. The conference highlighted the progress that has been made in developing new treatments and vaccines for herpes, and the ongoing efforts to find a cure for the virus.
These are just a few of the notable developments in herpes cure research and news in 2018. While there is still no cure for herpes, these advancements offer hope for the development of new treatments and vaccines in the future.